{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:39:12Z","timestamp":1760747952235,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jsbmb.2016.11.002","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T16:02:00Z","timestamp":1478188920000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease"],"prefix":"10.1016","volume":"167","author":[{"given":"Hideki","family":"Fujii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Yonekura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2016.11.002_bib0005","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0010","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1053\/j.ajkd.2009.02.010","article-title":"Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD","volume":"53","author":"Goldsmith","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/VHRM.S4822","article-title":"Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis","volume":"5","author":"Rennenberg","year":"2009","journal-title":"Vasc. Health Risk Manage."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0020","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/ndt\/gfs046","article-title":"Role of vitamin D in vascular calcification: bad guy or good guy","volume":"27","author":"Drueke","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mam.2008.04.002","article-title":"Protective and toxic effects of vitamin D on vascular calcification: clinical implications","volume":"29","author":"Zittermann","year":"2008","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0030","doi-asserted-by":"crossref","first-page":"269060","DOI":"10.4061\/2011\/269060","article-title":"The effect of paricalcitol on vascular calcification and cardiovascular disease in uremia: beyond PTH control","volume":"2011","author":"Cozzolino","year":"2011","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","article-title":"Differential effects of vitamin D receptor activators on vascular calcification in uremic rats","volume":"72","author":"Mizobuchi","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0040","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1681\/ASN.2007080902","article-title":"Vitamin D receptor activators can protect against vascular calcification","volume":"19","author":"Mathew","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2b","key":"10.1016\/j.jsbmb.2016.11.002_bib0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1476-5381.2011.01473.x","article-title":"VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects","volume":"164","author":"Wu-Wong","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsbmb.2014.12.002","article-title":"Different vitamin D receptor agonists exhibit differential effects on endothelial function and aortic gene expression in 5\/6 nephrectomized rats","volume":"148","author":"Wu-Wong","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0055","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/bph.13417","article-title":"Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction","volume":"173","author":"Fujii","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10557-015-6629-y","article-title":"The Vitamin D receptor activator maxacalcitol provides cardioprotective effects in diabetes mellitus","volume":"29","author":"Fujii","year":"2015","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0065","doi-asserted-by":"crossref","first-page":"184321","DOI":"10.1155\/2015\/184321","article-title":"International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data","volume":"2015","author":"Hedgeman","year":"2015","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0070","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1210\/jc.2015-2132","article-title":"Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism","volume":"100","author":"Tassone","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.11.002_bib0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2215\/CJN.12941213","article-title":"Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study","volume":"10","author":"Tentori","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"13","key":"10.1016\/j.jsbmb.2016.11.002_bib0080","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0085","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/ndt\/gfp728","article-title":"Assessment and significance of abdominal aortic calcification in chronic kidney disease","volume":"25","author":"Hanada","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0090","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0095","doi-asserted-by":"crossref","first-page":"F309","DOI":"10.1152\/ajprenal.00129.2014","article-title":"Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5\/6 nephrectomized rats","volume":"308","author":"Wu-Wong","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsbmb.2016.03.028","article-title":"Cardiac effect of vitamin D receptor modulators in uremic rats","volume":"163","author":"Mizobuchi","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0110","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ki.2012.322","article-title":"Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet","volume":"82","author":"Lau","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0115","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ki.2015.22","article-title":"Differential expression and regulation of klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats","volume":"87","author":"Ritter","year":"2015","journal-title":"Kidney Int."},{"issue":"Suppl. 3","key":"10.1016\/j.jsbmb.2016.11.002_bib0120","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1177\/089686080502503S13","article-title":"Association of vitamin D receptor gene polymorphisms with hypercalcemia in peritoneal dialysis patients","volume":"25","author":"Akcay","year":"2005","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.jsbmb.2016.11.002_bib0125","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1046\/j.1523-1755.1999.00678.x","article-title":"Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients","volume":"56","author":"Marco","year":"1999","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.11.002_bib0130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1523-1755.1998.00781.x","article-title":"Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease","volume":"53","author":"Yokoyama","year":"1998","journal-title":"Kidney Int."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016302977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016302977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:54:47Z","timestamp":1760745287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076016302977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":26,"alternative-id":["S0960076016302977"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.11.002","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}